traditional pathology workflows rely on the time-consuming review of individual pathology slides under the microscope, creating bottlenecks that can lead to less than optimal outcomes for patients.

Owkin has announced a partnership with AstraZeneca to create an AI gBRCA pre-screening solution designed to identify ...